Remed

리메드 · 302550

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$63.3M (₩87.3B)

Overview

Remed makes medical devices that use powerful magnetic fields and other energy-based technologies to treat neurological and psychiatric conditions, such as depression, ADHD, and stroke, as well as to manage pain and support physical rehabilitation, all without surgery.

Its products are used in clinical and hospital settings by medical professionals. The company's portfolio spans brain-stimulation devices, pain-management systems, and energy-based aesthetic and dermatology equipment, giving it a broad range across both therapeutic and cosmetic medical applications. Remed is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$17.8M
▼ −4.1% YoY
Operating profit · FY2025
US$526K
▼ −35.3% YoY
Net income · FY2025
−US$25.7K
Turned to loss

Revenue

  • FY2023US$13.4M
  • FY2024US$18.5M
  • FY2025US$17.8M

Operating profit

  • FY2023−US$2.1M
  • FY2024US$812.5K
  • FY2025US$526K

Net income

  • FY2023US$231.3K
  • FY2024US$5.3M
  • FY2025−US$25.7K

Key ratios (FY2025)

ROE
-0.1%
Debt/Eq
36.6%
Op. margin
3.0%
Net margin
-0.1%
Rev. YoY
▼ −4.1%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.